Catalyst Wire Dossier Catalyst Wire Dossier

LOARGYS

PEGZILARGINASE-NBLN · Immedica Pharma US Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LOARGYS, covering 2025-12-09 to 2026-02-23. Get the full timeline:

Most recent: FDA Approved: LOARGYS — Original Application (Immedica Pharma US Inc.)

See pricing